Skip to main content
SpringerLink
Log in

NSAID Gastric Ulceration: Predictive Value of Gastric pH, Mucosal Density of Polymorphonuclear Leukocytes, or Levels of IL-8 or Nitrite

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

NSAID use and Helicobacter pylori both cause damage to the gastric mucosa and can cause peptic ulcers. Our aim was to test the relationship between gastric mucosal polymorphonuclear leukocyte (PMN) infiltration and the severity of NSAID-induced gastric injury. H. pylori density, mucosal interleukin-8 (IL-8), and nitrite levels were assessed after receiving placebo and again after receiving 1000 mg of naproxen daily for three days. Histology was graded using a visual analog scale (0–5). IL-8 levels were assayed by ELISA and nitrite levels by Griess reaction. Eleven healthy volunteers with H. pylori infection entered. All had normal-appearing gastric mucosa after placebo. Postnaproxen gastric damage included three with none, one with mild, three with moderate, two with severe, and three were very severe mucosal injury (including one with an ulcer >5 mm). There was an inverse correlation between endoscopic score and the pH of the gastric juice post-therapy (R = −0.77, P = 0.004). There was no significant change in histologic or biochemical parameters from pretreatment levels. And none of the parameters (eg, PMN density) predicted endoscopic outcome. In conclusion, there was no relation between mucosal PMN density and endoscopic mucosa injury. PMN infiltration, while not predictive, may be a surrogate for an H. pylori infection-related increased risk of NSAID ulcers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Graham DY: Nonsteroidal anti-inflammatory drugs, Helicobacter pylori, and ulcers: Where we stand. Am J Gastroenterol 91:2080–2086, 1996

    Google Scholar 

  2. Cullen DJE, Hawkey GM, Greenwood DC, Humphreys H, Shepherd U, Logan RF, et al: Peptic ulcer bleeding in the elderly: Relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs. Gut 41:459–462, 1997

    Google Scholar 

  3. Chan FK, Sung JJ, Suen R, Lee YT, Wu JC, Leung WK, et al: Does eradication of Helicobacter pylori impair healing of nonsteroidal antiinflammatory drug associated bleeding peptic ulcers? A prospective randomized study. Aliment Pharmacol Ther 12:1201–1205, 1998

    Google Scholar 

  4. Wu CY, Poon SK, Chen GH, Chang CS, Yeh HZ: Interaction between Helicobacter pylori and non-steroidal anti-inflammatory drugs in peptic ulcer bleeding. Scand J Gastroenterol 33:234–237, 1999

    Google Scholar 

  5. Hawkey CJ, Karrasch JA, Szczepanski L, Walker DG, Barkun A, Swannell AJ, et al: Omeprazole compared with misoprostol for ulcers associated with nonsteroidal anti-inflammatory drugs. Omeprazole versus misoprostol for NSAID-induced ulcer management (OMNIUM) study group. N Engl J Med 338:727–734, 1998

    Google Scholar 

  6. Yeomans ND, Tulassay Z, Juhasz L, Racz I, Howard JM, Van Rensburg CJ, et al: A comparison of omeprazole with ranitidine foe ulcers associated with nonstroidal antiinflammatory drugs. Acid suppression trial: Ranitidine versus omeprazole for NSAID-associated ulcer treatment (ASTRONAUT) study group. N Engl J Med 338:719–726, 1998.

    Google Scholar 

  7. Hawkey CJ: Personal review: Helicobacter pylori, NSAIDs and cognitive dissonance. Aliment Pharmacol Ther 13:695–702, 1999

    Google Scholar 

  8. Aalykke C, Lauristen JM, Hallas J, Reinholdt S, Krogfelt K, Lauristen K: Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: A case—control study. Gastroenterology 116:1305–1309, 1999

    Google Scholar 

  9. Avunduk C, Suliman M, Gang D, Polakowski N, Eastwood GL: Gastroduodenal mucosal prostaglandid generation in patients with Helicobacter pylori before and after treatment with bismuth subsalicylate. Dig Dis Sci 36:431–434, 1991

    Google Scholar 

  10. Hudson N, Balsitis M, Filipowicz F, Hawkey CJ: Effect of Helicobacter pylori colonization on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs. Gut 34:748–751, 1993

    Google Scholar 

  11. Fu S, Ramanujam KS, Wong A, Fantry GT, Drachenberg CB, James SP, Meltzer SJ, Wilson KT: Increased expression and cellular localization od inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology 116:1319–1329, 1999

    Google Scholar 

  12. Agrawal NM, Roth S, Graham DY, White RH, Germain B, Brown JA, Stromatt SC: Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory druginduced gastric ulcer. A randomized, controlled trial. Ann Intern Med 115:195–200, 1991

    Google Scholar 

  13. Graham DY: Prevention of gastroduodenal injury induced by chronic nonsteroidal antiinflammatory drug therapy. Gastroenterology 96:675–681, 1989

    Google Scholar 

  14. Taha AS, Dahill S, Morran C, Hudson N, Hawkey CJ, Lee FD, Sturrock RD, Russell RI: Neutrophils, Helicobacter pylori, and nonsteroidal anti-inflammatory drug ulcers. Gastoenterology 116:254–258, 1999

    Google Scholar 

  15. Crabtree JE, Wyatt JI, Trejdosiewicz LK, Peichl P, Nichols PH, Ramsay N, Primrose JN, Lindley IJD: Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J Clin Pathol 46:61–66, 1994

    Google Scholar 

  16. Crabtree JE, Covacci A, Farmery SM, Xiang Z, Tompkins DS, Perry S, Lindley IJ, Rappuoli R: Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with Cag A positive phenotype. J Clin Pathol 48:41–45, 1995

    Google Scholar 

  17. Yamaoka Y, Kita M, Kodama T, Sawai N, Tanahashi T, Kashima K, Imanishi J: Chemokines in the gastric mucosa in Helicobacter pylori infection. Gut 42:609–617, 1998

    Google Scholar 

  18. Yamaoka Y, Kodama T, Kita M, Imanishi J, Kashima K, Graham DY: Relation between clinical presentation, Helicobacter pylori density, interleukin 1βand 8 production, and cagA status. Gut 45:804–811, 1999

    Google Scholar 

  19. Yamaoka Y, Kita M, Kodama T, Sawai N, Kashima K, Imanishi J: Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut 41:442–451, 1997

    Google Scholar 

  20. Kugler P, Drenckhahn D: Intrinsic source of stomach NO. Nature 370:25–26, 1994

    Google Scholar 

  21. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109–142, 1991

    Google Scholar 

  22. Stark ME, Szurszewski JH: Role of nitric oxide in gastrointestinal and hepatic function and disease. Gastroenterology 103:1928–1949, 1992

    Google Scholar 

  23. MacNaughton WK, Cirino G, Wallace JL: Endotheliumderived relaxing factor (nitric oxide) has protective actions in the stomach. Life Sci 45:1869–1876, 1989

    Google Scholar 

  24. Elliott SN, Mcknight W, Cirino G, Wallance JL: A nitric oxide-releasing nonsteroidal antiinflammatory drug accelerates gastric ulcer healing in rats. Gastroenterology 109:524–530, 1995

    Google Scholar 

  25. Wallace JL, Mcknight W, Del Soldato P, Baydoun AR, Cirino G: Anti-thrombotic effects of a nitric oxide-releasing, gastricsparing aspirin derivative. J Clin Invest 96:2711–2718, 1995

    Google Scholar 

  26. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needleman P: Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 90:7240–7244, 1993

    Google Scholar 

  27. Shiotani A, Yanaoka K, Iguchi M, Saika A, Itoh H, Nishioka S: Helicobacter pylori infection reduces intraluminal nitric oxide in humans. J Gastroenterol 34:668–674, 1999

    Google Scholar 

  28. Iguchi M, Shiotani A, Nishioka S: Helicobacter pylori-infection reduces intraluminal nitric oxide. Scand J Gastroenterol 35:694–698, 2000

    Google Scholar 

  29. El-Zimaity HMT, Graham DY, Al-Assi MT, Malaty H, Karttunen TJ, Graham DP, Huberman RM, Genta RM: Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. Hum Pathol 27:35–41, 1996

    Google Scholar 

  30. Graham DY, Malaty HM: Alendronate gastric ulcers. Aliment Pharmacol Ther 13:515–519, 1999

    Google Scholar 

  31. Lanza FL, Graham DY, Davis RE, Rack MF: Endoscopic comparison of cimetidine and sucralfate for prevention of naproxen-induced acute gastroduodenal injury. Effect of scoring method. Dig Dis Sci 35:1494–1499, 1990

    Google Scholar 

  32. Wolfe MM, Lichtenstein DR, Singh G: Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 340:1888–1899, 1999

    Google Scholar 

  33. Singh G, Triadafilopoulos G: Epidemiology of NSAID induced gastrointestinal complications. J Rheumatol 56(suppl 26):18–24, 1999

    Google Scholar 

  34. Langman MJ Weil J, Wainwright P, Lawson DH, Rawlins MD, Logan RF, Murphy M, Vessey MP, Colin-Jones DG: Risks of bleeding peptic ulcer associated with individual nonsteroidal anti-inflammatory drugs. Lancet 343:1075–1078, 1994

    Google Scholar 

  35. Garcia Rodriguez LA, Jick H: Risk of upper gastrointestinal bleeding and perforation associated with individual nonsteroidal anti-inflammatory drugs. Lancet 343:769–772, 1994

    Google Scholar 

  36. Silverstein FE, Graham DY, Senior JR, Davies HW, Struthers BJ, Bittman RM: Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs: A randomized, doubleblind, placebo-controlled trial. Ann Intern Med 123:241–249, 1995

    Google Scholar 

  37. Needleman P, Isakson PC: The discovery and function of COX-2. J Rheumatol 24(suppl 49):6–8, 1997

    Google Scholar 

  38. Masferrer JL, Seibert K, Zweifel B, Needleman P: Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc Natl Acad Sci USA 89:3817–3921, 1992

    Google Scholar 

  39. Crofford LJ: COX-1 and COX-2 tissue expression: Implications and predictions. J Rheumatol 24(suppl 49):15–19, 1997

    Google Scholar 

  40. Vane J: Towards a better aspirin. Nature 367:215–216, 1994

    Google Scholar 

  41. Schoen RT, Vender RJ: Mechanisms of nonsteroidal antiinflammatory drug-induced gastric damage. Am J Med 86:449–458, 1989

    Google Scholar 

  42. Laine L, Sloane R, Ferretti M, Cominelli F: A randomized double-blind comparison of placebo, etodolac, and naproxen on gastrointestinal injury and prostaglandin production. Gastrointest Endosc 42:428–433, 1995

    Google Scholar 

  43. Whittle BJR: Mechanisms underlying gastric mucosal damage induced by indomethacin and bile salts, and the actions of prostaglandins. Br J Pharmacol 60:455–460, 1977

    Google Scholar 

  44. Wolfe MM, Soll AH: The physiology of gastric acid secretion. N Engl J Med 319:1707–1715, 1988

    Google Scholar 

  45. Rees RC: Cytokines as biological response modifiers. J Clin Pathol 45:93–98, 1993

    Google Scholar 

  46. Hamlet A, Lindholm C, Nillson O, Olbe L: Aspirin-induced gastritis, like Helicobacter pylori-induced gastritis, disinhibits acid secretion in human: Relation to cytokine expression. Scand J Gastroenterol 33:346–356, 1998

    Google Scholar 

  47. Wallace JL: Non-steroidal anti-inflammatory drug gastropathy and cytoprotection: Pathogenesis and mechanisms reexamined. Scand J Gastroenterol 192:3–8, 1992

    Google Scholar 

  48. Lipscomb GR, Wallis N, Armstrong G, Goodman MJ, Rees WDW: Influence of Helicobacter pylori on gastric mucosal adaptation to naproxen in man. Dig Dis Sci 41:1583–1588, 1996.

    Google Scholar 

  49. Laine L, Cominelli F, Sloane R, Casini-Raggi V, Marin-Sorensen M, Weinstein WM: Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: A controlled double-blind trial. Aliment Pharmacol Ther 9:127–135, 1995

    Google Scholar 

  50. Macdonald WC: Correlation of mucosal histology and aspirin intake in chronic gastric ulcer. Gastroenterology 65:381–389, 1973

    Google Scholar 

  51. Goggin PM, Collins DA, Jazrawi RP, Jackson PA, Corbishley CM, Bourke BE, Northfield TC: Prevalence of Helicobacter pylori infection and its effect on symptoms and nonsteroidal anti-inflammatory drug induced gastrointestinal damage in patients with rheumatoid arthritis. Gut 34:1677–1680, 1993

    Google Scholar 

  52. Peterson WL, Lee E, Feldman M: Relationship between Campylobacter pylori and gastritis in healthy humans after administration of placebo or indomethacin. Gastroenterology 95:1185–1197, 1988

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, VA Medical Center, Houston, Texas, USA

    Akiko Shiotani, Yoshio Yamaoka, Hala M. T. El-Zimaity, M. Ali Saeed, Waqar A. Qureshi & David Y. Graham

  2. Baylor College of Medicine, Houston, Texas, USA

    Akiko Shiotani, Yoshio Yamaoka, Hala M. T. El-Zimaity, M. Ali Saeed, Waqar A. Qureshi & David Y. Graham

Authors
  1. Akiko Shiotani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoshio Yamaoka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hala M. T. El-Zimaity
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Ali Saeed
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Waqar A. Qureshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. David Y. Graham
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shiotani, A., Yamaoka, Y., El-Zimaity, H.M.T. et al. NSAID Gastric Ulceration: Predictive Value of Gastric pH, Mucosal Density of Polymorphonuclear Leukocytes, or Levels of IL-8 or Nitrite. Dig Dis Sci 47, 38–43 (2002). https://doi.org/10.1023/A:1013251100950

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1013251100950

Search

Navigation